FindTrial
Sign In

The effect of dexmedetomidine on midazolam paradoxical reaction: A single-center, prospective, double-blind, randomized, controlled clinical trial

The effect of dexmedetomidine on midazolam paradoxical reaction: A single-center, prospective, double-blind, randomized, controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113497
Enrollment
Unknown
Registered
2025-11-28
Start date
2024-09-07
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:Midazolam+ Dexmedetomidine
Control group:Midazolam Sodium+ Chloride Injection

Sponsors

Mianyang Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: 1.ASA Classification I-II; 2.BMI <23.9kg/m^2; 3.Family consent to enter this study; 4. Age: 1-3 years

Exclusion criteria

Exclusion criteria: 1.Comorbid neurological/psychiatric disorders; 2.Combined with damage to important organs; 3.Abnormal liver and kidney function; 4.Comorbid nasal disease; 5.Allergy to the study drug;

Design outcomes

Primary

MeasureTime frame
Paradoxical response;—

Secondary

MeasureTime frame
Adverse reactions;ramsay sedation scale;—

Countries

China

Contacts

Public ContactLiu yi

Mianyang Maternal and Child Health Hospital

289326453@qq.com+86 816 222 3460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026